Literature DB >> 11083191

Accuracy of exercise stress technetium 99m sestamibi SPECT imaging in the evaluation of the extent and location of coronary artery disease in patients with an earlier myocardial infarction.

A Elhendy1, F B Sozzi, R T van Domburg, J J Bax, M L Geleijnse, R Valkema, E P Krenning, J R Roelandt.   

Abstract

BACKGROUND: This study assessed the accuracy of exercise methoxy isobutyl isonitrile (MIBI) single photon emission computed tomography (SPECT) in the evaluation of the extent of coronary artery disease (CAD) in patients with an earlier myocardial infarction. METHODS AND
RESULTS: We studied 135 patients (mean age, 57+/-10 years; 115 men) at a mean of 4.1 years (median, 1 year) after myocardial infarction with symptom-limited bicycle exercise stress and rest MIBI SPECT imaging. Coronary angiography was performed within 3 months. Significant CAD was defined as a stenosis of 50% or larger in luminal diameter in 1 or more major coronary arteries. Myocardial perfusion defects (fixed, reversible, or both) were detected in 107 of the 113 patients with significant CAD and in 10 of the 22 patients without significant CAD (sensitivity, 95%; CI, 91 to 99; specificity, 55%; CI, 46 to 63, and accuracy, 88%; CI, 82 to 94). The specificity rate increased to 73% (CI, 65 to 80) by using only reversible perfusion defects as a means of predicting CAD. Reversible perfusion abnormalities were more frequent in patients with multivessel CAD than in patients with single-vessel CAD (51 of 64 [80%] vs. 27 of 49 [55%], P<.01). Myocardial perfusion abnormalities in 2 vascular regions, which is suggestive of multivessel CAD, were detected in 35 of the 64 patients with and in 9 of the 71 patients without multivessel CAD (sensitivity for detecting CAD in more than one vascular region, 55%; CI, 46 to 63, specificity, 87%; CI, 81 to 93, and accuracy, 72%; CI, 64 to 80). The sensitivity rates for the diagnosis of left anterior descending coronary artery, left circumflex, and right coronary artery based on any defect were 80%, 70%, and 63%, respectively. The corresponding specificity rates were 70%, 76%, and 73%, respectively.
CONCLUSIONS: Exercise MIBI SPECT imaging is an accurate method for the diagnosis and localization of CAD in patients with an earlier myocardial infarction. The technique provides a high specificity and moderate sensitivity for the diagnosis of multivessel CAD on the basis of myocardial perfusion abnormalities in more than 1 vascular region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083191     DOI: 10.1067/mnc.2000.107426

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  27 in total

Review 1.  Technetium 99m sestamibi in the assessment of chronic coronary artery disease.

Authors:  D S Berman; H Kiat; K Van Train; E Garcia; J Friedman; J Maddahi
Journal:  Semin Nucl Med       Date:  1991-07       Impact factor: 4.446

2.  Prediction of severe coronary artery disease by combined rest and exercise radionuclide angiocardiography and tomographic perfusion imaging with technetium 99m-labeled sestamibi: a comparison with clinical and electrocardiographic data.

Authors:  S Borges-Neto; L J Shaw; K L Kesler; M W Hanson; E D Peterson; E I Morris; R E Coleman
Journal:  J Nucl Cardiol       Date:  1997 May-Jun       Impact factor: 5.952

3.  Thallium-201 exercise testing in patients 6-8 weeks after myocardial infarction: limited value for the detection of multivessel disease.

Authors:  E E van der Wall; M J Eenige van; F C Visser; A G Scholtalbers; J P Roos
Journal:  Eur Heart J       Date:  1985-01       Impact factor: 29.983

4.  Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

Authors:  K E Fleischmann; M G Hunink; K M Kuntz; P S Douglas
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

5.  Diagnostic value and incremental contribution of bicycle exercise, first-pass radionuclide angiography, and 99mTc-labeled sestamibi single-photon emission computed tomography in the identification of coronary artery disease in patients without infarction.

Authors:  A S Hambÿe; A Vervaet; S Lieber; R Ranquin
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

6.  Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: comparison of thallium 201 and technetium 99m-labeled tetrofosmin.

Authors:  R C Hendel; M A Parker; F J Wackers; P Rigo; A Lahiri; B L Zaret
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

Review 7.  Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.

Authors:  J Maddahi; H Kiat; K F Van Train; F Prigent; J Friedman; E V Garcia; N Alazraki; E G DePuey; K Nichols; D S Berman
Journal:  Am J Cardiol       Date:  1990-10-16       Impact factor: 2.778

8.  Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms.

Authors:  K F Van Train; E V Garcia; J Maddahi; J Areeda; C D Cooke; H Kiat; G Silagan; R Folks; J Friedman; L Matzer
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

Review 9.  Comparison of thallium-201 and technetium-99m methoxyisobutyl isonitrile.

Authors:  F J Wackers
Journal:  Am J Cardiol       Date:  1992-11-05       Impact factor: 2.778

Review 10.  A review of cardiac imaging with sestamibi and teboroxime.

Authors:  J A Leppo; E G DePuey; L L Johnson
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

View more
  8 in total

1.  Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: impact of scintigraphic extent of coronary artery disease.

Authors:  Abdou Elhendy; Arend F L Schinkel; Ron T van Domburg; Jeroen J Bax; Roelf Valkema; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

2.  Patients with left bundle branch block pattern and high cardiac risk myocardial SPECT: does the current management suffice?

Authors:  T J F Ten Cate; J C Kelder; H W M Plokker; J F Verzijlbergen; N M van Hemel
Journal:  Neth Heart J       Date:  2013-03       Impact factor: 2.380

3.  Peri-infarct ischaemia assessed by cardiovascular MRI: comparison with quantitative perfusion single photon emission CT imaging.

Authors:  E Gerbaud; H Cochet; E Bullier; C Ragot; S H Gilbert; H Douard; Y Pucheu; F Laurent; P Coste; L Bordenave; M Montaudon
Journal:  Br J Radiol       Date:  2014-04-29       Impact factor: 3.039

4.  Incremental value of combining 64-slice computed tomography angiography with stress nuclear myocardial perfusion imaging to improve noninvasive detection of coronary artery disease.

Authors:  Akira Sato; Toshihiro Nozato; Hiroyuki Hikita; Shinsuke Miyazaki; Yoshihide Takahashi; Taishi Kuwahara; Atsushi Takahashi; Michiaki Hiroe; Kazutaka Aonuma
Journal:  J Nucl Cardiol       Date:  2009-09-24       Impact factor: 5.952

5.  Variability of myocardial ischemic responses to mental versus exercise or adenosine stress in patients with coronary artery disease.

Authors:  Mustafa Hassan; Kaki M York; Qin Li; Dorian G Lucey; Roger B Fillingim; David S Sheps
Journal:  J Nucl Cardiol       Date:  2008-06-12       Impact factor: 5.952

6.  Incidence and predictors of heart failure during long-term follow-up after stress Tc-99m sestamibi tomography in patients with suspected coronary artery disease.

Authors:  Abdou Elhendy; Arend F L Schinkel; Ron T van Domburg; Jeroen J Bax; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

7.  Accuracy of myocardial perfusion imaging in detecting multivessel coronary artery disease: A cardiac CZT study.

Authors:  Alessia Gimelli; Riccardo Liga; Valerio Duce; Annette Kusch; Alberto Clemente; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2016-02-03       Impact factor: 5.952

8.  Frequency and severity of myocardial perfusion abnormalities using Tc-99m MIBI SPECT in cardiac syndrome X.

Authors:  Mohsen Saghari; Majid Assadi; Mohammad Eftekhari; Mohammad Yaghoubi; Armaghan Fard-Esfahani; Jan-Mohammad Malekzadeh; Babak Fallhi Sichani; Davood Beiki; Abbas Takavar
Journal:  BMC Nucl Med       Date:  2006-02-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.